Latest News

Wednesday, July 27, 2016 | Product Releases, CenterVue

CenterVue Launches Fixation Training Module to Help Low Vision Patients with Central Vision Loss

CenterVue announced it has received FDA 510(k) clearance for Fixation Training for the MAIA platform, an innovative technology designed to help patients rehabilitate from vision loss using audio feedb…

Read the full story

Wednesday, July 27, 2016 | Product Releases, Modernizing Medicine

Modernizing Medicine Releases New Software Suite for Medical Specialties

Modernizing Medicine revealed the latest edition of its software, modmed 5.0, a comprehensive specialty-specific suite developed to address the diverse and growing needs of medical practices. The upda…

Read the full story

Wednesday, July 27, 2016 | Management/Leadership, AcuFocus

AcuFocus Appoints Alan Waterhouse President and Chief Operating Officer; William Link, PhD, to Become Chairman of the Board

AcuFocus announced the appointment of Alan Waterhouse as the company’s President and Chief Operating Officer, and William Link, PhD, as Chairman of the Board. Mr. Waterhouse will also take a sea…

Read the full story

Wednesday, July 27, 2016 | Management/Leadership, Carl Zeiss Meditec

James Mazzo Named Global President of Ophthalmology at Carl Zeiss Meditec

James V. Mazzo will join Carl Zeiss Meditec as Global President of Ophthalmology and will be responsible for the new Strategic Business Unit Ophthalmology as well as Carl Zeiss Meditec's US Sales …

Read the full story

Tuesday, July 26, 2016 | Dry Eye, Shire

Shire Prices Xiidra at $5K per year - Right on Par with Restasis

Dublin-based Shire has decided to roll out its new product - green-lighted by the FDA earlier this month - at about $5,000 per year, according to Evercore ISI analyst Umer Raffat. A 30-day supply will…

Read the full story

Tuesday, July 26, 2016 | Product Releases

Bascom Palmer Eye Institute Launches Dynamic New Master's Degree

Bascom Palmer Eye Institute has launched the world's first Master's degree in Vision Science and Investigative Ophthalmology (MVSIO). This program offers comprehensive training in ophthalmic t…

Read the full story

Tuesday, July 26, 2016 | Clinical Trials, Glaucoma

Sight Sciences Receives Full Investigational Device Exemption Approval from the FDA to Initiate the VISCO 360 Versus SLT Glaucoma Trial

Sight Sciences announced that it has received full IDE approval from the FDA to initiate the world's first clinical trial comparing ab interno canaloplasty with Selective Laser Trabeculoplasty (SL…

Read the full story

Tuesday, July 26, 2016 | Clinical Trials, Clearside Biomedical

Clearside Biomedical Announces Patient Treatment Comparison from the Phase 2 Trial (TANZANITE) in Patients with Macular Edema Associated with RVO

Clearside Biomedical reported additional top-line data from its phase 2 clinical trial (TANZANITE), according to a company news release. The 46-patient, phase 2 trial, with top-line results originally…

Read the full story

Tuesday, July 26, 2016 | Medical Studies

Smell And Eye Tests One Step Closer For Detection Of Memory Decline And Dementia

The potential of odor identification testing and physical changes in and around the eye to detect cognitive impairment and Alzheimer's disease at an early stage was bolstered by new evidence from …

Read the full story

Tuesday, July 26, 2016 | Conferences, American Academy of Ophthalmology

AAO Ebola and Zika Virus Webinar for Ophthalmologists

The American Academy of Ophthalmology is hosting a live webinar on the Ebola and Zika viruses and their impact on ocular health in August. This webinar is designed for comprehensive ophthalmologists a…

Read the full story

Tuesday, July 26, 2016 | Clinical Trials

Opthea Reports Positive Data From Wet AMD Clinical Trial

Opthea Limited announced positive data from its ongoing first-in-human clinical trial of OPT-302, a novel VEGF-C/D 'Trap' therapy for wet age-related macular degeneration (AMD). The study i…

Read the full story

Monday, July 25, 2016 | Medical Studies

Visual Pigment Rhodopsin Forms Two-Molecule Complexes In Vivo

The study of rhodopsin -- the molecule that allows the eye to detect dim light -- has a long and well-recognized history of more than 100 years. Nevertheless, there is still controversy about the …

Read the full story

Monday, July 25, 2016 | Conferences

Meeting Scheduled for International Forum for Scleral Lens Research (IFSLR)

The first International Forum for Scleral Lens Research (IFSLR) is scheduled for December 5, 2016 at the Texas Eye Research and Technology Center, University of Houston College of Optometry. The IFSLR…

Read the full story

Monday, July 25, 2016 | Management/Leadership, ReVision Optics

ReVision Optics Appoints Frank Shields Vice President of Sales Worldwide

ReVision Optics announced the appointment of Frank Shields to the newly created position of vice president of sales worldwide, effective immediately. Mr. Shields brings more than 25 years of experienc…

Read the full story

Monday, July 25, 2016 | Medical Studies

Cataract Surgery Has No Clear Link With AMD: Korean Survey

This is a cross-sectional study and cannot assess progression of AMD, but instead only analyze its association with cataract surgery. It was done in a predominantly Asian population who probably have …

Read the full story
Load More